Type 2 diabetes patients with albuminuric DKD Sodium-glucose cotransporter 2 inhibitors (SGLT2i), Prescription rates, Diabetic kidney disease, Real-world data, Thai
Conditions
Interventions
T2D patients with albuminuric DKD received SGLT2i medications for treatment,T2D patients with albuminuric DKD not received SGLT2i medications for treatment
Treatment,Treatment
Received SGLT2i ,Not received SGLT2i
Sponsors
ViMUT-Theptarin Hospital
Eligibility
Sex/Gender
All
Age
15 Years to 80 Years
Inclusion criteria
Inclusion criteria: T2D patients with albuminuric DKD and follow-up at least 3 times in 2023
Exclusion criteria
Exclusion criteria: Patients ages < 15 years or > 80 years Patients with normoalbuminuria, eGFR < 20 mL/min/1.73 m2, Patients who followed-up less than 3 times in 2023 Patients with type 1 diabetes mellitus and patients with other types of diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prescription rates at time of study Percentage | — |
Secondary
| Measure | Time frame |
|---|---|
| factors associated at time of study Multivariate analysis,Prescription rates at time of study Percentage | — |
Countries
Thailand
Contacts
Public ContactPeachaphol Chongvoranond
ViMUT Theptarin Hospital
Outcome results
None listed